Durham, NC- Regado Biosciences, Inc., a privately-held biopharmaceutical company focused on the discovery and development of antidote-controlled antithrombotics, announced today the completion of a $23 million Series C financing. (more…)
Southeast BIO (SEBIO), a public/private partnership formed in 1999 to promote the growth of the life sciences economy in the Southeast, has named Stephanie Adams, Ph.D., as its new Executive Director. Dr. Adams replaces Anne Wein, SE Bio’s first Executive Director. Wein announced her resignation in early January in anticipation of the birth of her first child in March. (more…)
By RICK SMITH
Posted: Mar. 12, 2007
RESEARCH TRIANGLE PARK, N.C. – Stephanie Adams, a patent agent with the King & Spalding law firm in Atlanta since 2002, is the new executive director of the Southeast BIO. (more…)
Liquidia, a Morrisville, N.C.-based developer of fluoro-polymer materials for the life sciences and advanced materials market, has raised $16 million in Series B funding. New Enterprise Associates led the deal, and was joined by return backers like Firelake Capital and the Wakefield Group. (more…)
By Rebecca Kaufman, Counsel, King & Spalding LLP, and Chair, Southeast BIO
In 2005, the $540 million purchase of Emory University’s royalty interest in emtricitabine (Emtriva) was big news. The largest ever deal of its kind for a U.S. university, it brought significant recognition and resources to Emory’s research programs. (more…)
